Chan Claire Hian Tzer, Munusamy Prabhakaran, Loke Sau Yeen, Koh Geok Ling, Yang Audrey Zhi Yi, Law Hai Yang, Yoon Chui Sheun, Wong Chow Yin, Yong Wei Sean, Wong Nan Soon, Ng Raymond Chee Hui, Ong Kong Wee, Madhukumar Preetha, Oey Chung Lie, Ho Gay Hui, Tan Puay Hoon, Tan Min Han, Ang Peter, Yap Yoon Sim, Lee Ann Siew Gek
Division of Medical Sciences, Humphrey Oei Institute of Cancer Research, National Cancer Centre, Singapore.
DNA Diagnostic and Research Laboratory, KK Women's and Children's Hospital, Singapore.
Oncotarget. 2018 Jan 31;9(16):12796-12804. doi: 10.18632/oncotarget.24374. eCollection 2018 Feb 27.
Genome-wide association studies (GWAS) have proven highly successful in identifying single nucleotide polymorphisms (SNPs) associated with breast cancer (BC) risk. The majority of these studies are on European populations, with limited SNP association data in other populations. We genotyped 51 GWAS-identified SNPs in two independent cohorts of Singaporean Chinese. Cohort 1 comprised 1294 BC cases and 885 controls and was used to determine odds ratios (ORs); Cohort 2 had 301 BC cases and 243 controls for deriving polygenic risk scores (PRS). After age-adjustment, 11 SNPs were found to be significantly associated with BC risk. Five SNPs were present in <1% of Cohort 1 and were excluded from further PRS analysis. To assess the cumulative effect of the remaining 46 SNPs on BC risk, we generated three PRS models: Model-1 included 46 SNPs; Model-2 included 11 statistically significant SNPs; and Model-3 included the SNPs in Model-2 but excluded SNPs that were in strong linkage disequilibrium with the others. Across Models-1, -2 and -3, women in the highest PRS quartile had the greatest ORs of 1.894 (95% CI = 1.157-3.100), 2.013 (95% CI = 1.227-3.302) and 1.751 (95% CI = 1.073-2.856) respectively, suggesting a direct correlation between PRS and BC risk. Given the potential of PRS in BC risk stratification, our findings suggest the need to tailor the selection of SNPs to be included in an ethnic-specific PRS model.
全基因组关联研究(GWAS)已被证明在识别与乳腺癌(BC)风险相关的单核苷酸多态性(SNP)方面非常成功。这些研究大多针对欧洲人群,其他人群的SNP关联数据有限。我们对新加坡华裔的两个独立队列中的51个经GWAS鉴定的SNP进行了基因分型。队列1包括1294例BC病例和885例对照,用于确定比值比(OR);队列2有301例BC病例和243例对照,用于推导多基因风险评分(PRS)。年龄调整后,发现11个SNP与BC风险显著相关。5个SNP在队列1中的出现频率低于1%,被排除在进一步的PRS分析之外。为了评估其余46个SNP对BC风险的累积影响,我们生成了三个PRS模型:模型1包括46个SNP;模型2包括11个具有统计学意义的SNP;模型3包括模型2中的SNP,但排除了与其他SNP处于强连锁不平衡状态的SNP。在模型1、模型2和模型3中,PRS四分位数最高的女性的OR分别为1.894(95%CI = 1.157 - 3.100)、2.013(95%CI = 1.227 - 3.302)和1.751(95%CI = 1.073 - 2.856),表明PRS与BC风险之间存在直接相关性。鉴于PRS在BC风险分层中的潜力,我们的研究结果表明需要针对特定种族的PRS模型量身定制要纳入的SNP选择。